Latest Breaking News On - Point pharmaceuticals - Page 12 : comparemela.com

Essex Investment Management Co LLC Sells 2,789 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT)

Essex Investment Management Co LLC Sells 2,789 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Darioa paggiarinoToth financial advisory corpJpmorgan chase coSchonfeld strategic advisorsEyepoint pharmaceuticalsEyepoint pharmaceuticals incEyepoint pharmaceuticals stock performanceTower research capitalEyepoint pharmaceuticals profileBarclays plcLazard asset managementQuarter for eyepoint pharmaceuticalsNews ratings for eyepoint pharmaceuticals dailyEssex investment management coEssex investment managementFree report

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported positive Phase 2 DAVIO 2 topline results showing all primary and secondary.

United statesMacau generalHong kongCarl regilloJay dukerChristina tartagliaCharlesc wykoffAmy phillipsGlobenewswire incEyepoint pharmaceuticals nasdaqThomas jefferson universityEyepoint pharmaceuticals incExchange commissionEquinox sciencesEyepoint pharmaceuticalsGreen room communications

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongMacau generalCarl regilloJay dukerCharlesc wykoffChristina tartagliaAmy phillipsGreen room communicationsExchange commissionEyepoint pharmaceuticalsThomas jefferson universityDrug administrationEquinox sciencesEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals inc

Insider Selling: EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Insider Sells 49,325 Shares of Stock

Insider Selling: EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Insider Sells 49,325 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa paggiarinoNews ratings for eyepoint pharmaceuticals dailyLazard asset managementJpmorgan chase coQuarter for eyepoint pharmaceuticalsEyepoint pharmaceuticals incInstitutional trading of eyepoint pharmaceuticalsChina universal asset management coInvestment advisersToth financial advisory corpTower research capitalEyepoint pharmaceuticalsEyepoint pharmaceuticals tradingGet free reportPoint pharmaceuticalsOne financial

Head-To-Head Survey: EyePoint Pharmaceuticals (NASDAQ:EYPT) & Seer (NASDAQ:SEER)

Head-To-Head Survey: EyePoint Pharmaceuticals (NASDAQ:EYPT) & Seer (NASDAQ:SEER)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRedwood citySalk instituteDiscovery life sciencesEyepoint pharmaceuticals incSeer incNews ratings for eyepoint pharmaceuticals dailySivida corpBroad instituteOregon health science universitySeer biosciences incSalk institute for biologicalEyepoint pharmaceuticalsGet free reportPoint pharmaceuticalsGiven seer